Zentiva has become one of the receivers of the European grant within Horizon 2020, supporting exchange of young researchers between academic and industrial sectors.
News from Zentiva
This section is for journalists and media professionals and contains comprehensive information about Zentiva.
-
August 15, 2019 / LinkedIn
-
August 14, 2019 / Featured
-
August 8, 2019 / LinkedIn
-
June 26, 2019 / LinkedIn
-
June 4, 2019 / LinkedIn
-
May 31, 2019 / Press Releases
Zentiva announces completion of Solacium Pharma acquisition
-
May 22, 2019 / LinkedIn
-
April 11, 2019 / LinkedIn
-
April 1, 2019 / Press Releases
Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
-
May 31, 2019 / Press Releases
Zentiva announces completion of Solacium Pharma acquisition
-
April 1, 2019 / Press Releases
Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
-
March 13, 2019 / Press Releases
Zentiva Group a.s. and Siyiara Enterprises have signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma.
-
March 5, 2019 / Press Releases
The Parc (Pharmaceutical Applied Research Center) is marking its five-year anniversary by launching The Parc Awards at a ceremony held at Zentiva Headquarters in Prague on March 5th.
-
January 25, 2019 / Press Releases
Zentiva is investing EUR 30 million to maximize its manufacturing site capabilities in Prague.
-
January 15, 2019 / Press Releases
Zentiva is very pleased to announce the appointment of Nick Haggar to the role of Chief Executive Officer (CEO), effective as of February 11th, 2019.
-
October 1, 2018 / Press Releases
oday marks generics manufacturer Zentiva’s first day as an independent organization, following completion of the company’s previously announced divestment from Sanofi.
-
June 28, 2018 / Press Releases
Sanofi and Advent International (“Advent”) have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion (enterprise value).
-
August 14, 2019 / Featured
Zentiva has become one of the receivers of the European grant within Horizon 2020, supporting exchange of young researchers between academic and industrial sectors.
-
February 6, 2019 / Featured
For the 4th year in a row, Zentiva has been named as the most prestigious Employer in the Healthcare & Pharmacy sector in Czech Republic at the TOP Employers competition.
-
November 23, 2018 / Featured
Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe.
Our Visual Identity
Logo
 |
|
|
 |
Pantone |
2727 |
 |
Pantone |
339 |
Press Relations
 |
Ines WindischHead of Corporate Affairs |